Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy.Oncotarget.(2016).
Establishment and Analysis of Cancer Stem-Like and Non-Cancer Stem-Like Clone Cells from the Human Colon Cancer Cell Line SW480.Plos One11, e0158903.(2016).
The future of immunotherapy for sarcoma.Expert Opin Biol Ther.(2016).